Comorbid vision and cognitive impairments in older adults hospitalized for acute myocardial infarction. (14th July 2020)

• Record Type: Journal Article
• Authors: Whitson, Heather E; Hajduk, Alexandra M; Song, Xuemei; Geda, Mary; Tsang, Sui; Brush, John; Chaudhry, Sarwat I
• Is Part Of: Journal of comorbidity. Volume 10(2020)
• Publication Date: 2020-07-14
• Subjects: Vision -- cognition -- cardiovascular disease -- hospital -- aging; Chronic diseases -- Periodicals; Comorbidity -- Periodicals; Chronic diseases -- Epidemiology -- Periodicals; Comorbidity; Chronic Disease; Electronic journals; Periodicals; Fulltext; Internet Resources; Periodicals; Periodical; 616.044
• DOI: 10.1177/2235042X20940493
• Languages: English
• ISSNs: 2235-042X

Abstract

Older patients presenting with acute myocardial infarction (AMI) often have comorbidities. Our objective was to examine how outcomes differ by cognitive and vision status in older AMI patients. We use data from a prospective cohort study conducted at 94 hospitals in the United States between January 2013 and October 2016 that enrolled men and women aged ≥75 years with AMI. Cognitive impairment (CI) was defined as telephone interview for cognitive status (TICS) score <27; vision impairment (VI) and activities of daily living (ADLs) were assessed by questionnaire. Of 2988 senior AMI patients, 260 (8.7%) had CI but no VI, 858 (28.7%) had VI but no CI, and 251 (8.4%) had both CI/VI. Patients in the VI/CI group were most likely to exhibit geriatric syndromes. More severe VI was associated with lower (worse) scores on the TICS ( β −1.53, 95% confidence interval (CI) −1.87 to −1.18). In adjusted models, compared to participants with neither impairment, participants with VI/CI were more likely to die (hazard ratio 1.61, 95% CI 1.10–2.37) and experience ADL decline (odds ratio 2.11, 95% CI 1.39–3.21) at 180 days. Comorbid CIs and VIs were associated with high rates of death and worsening disability after discharge among seniors hospitalized for AMI. Future research should evaluate protocols to accommodate these impairments during AMI presentations and optimize decision-making and outcomes.